Skip to main content
Board of Directors
A word from the CEO
The AGIR program
Platform of Expertise
News & events
To answer health and environmental challenges
Next generation anti-infectives
Active ingredients of natural origin
Anne ABRIAT-HEMMENDINGER appointed to the Board of Directors of DEINOVE
Her proven experience in the beauty industry, particularly within the L'Oréal Group, will be a key...
The US Department of Defense and Deinove will present impactful R&D results during the coming ASM 2019
L’USAMRIID (United States Army Medical Research Institute of Infectious Diseases) evaluated DNV3681...
More press releases
Annual Shareholders’ meeting
The annual Shareholders’ meeting will be held on May 20, 2019 in Paris
Find all the information and forms for voting by post or by proxy
In the Medias
Labiotech.eu | Life at its Limits: Meet the Extremophiles Being Embraced by the Biotech Industry
French biotech Deinove has an enviable collection of thousands of species of rare microbes that the company has been collecting since it...
Arte | Antibiotiques, la fin du miracle ?
Le XXIe siècle marquera-t-il la fin de l’ère des antibiotiques, ramenant la médecine deux cents ans en arrière ? Malgré leurs efforts, les...
More press coverage